Skip to main content

MoneyWorks4Me

Cipla informs about analyst meet

06 Jun 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it attached schedule of Analyst/ Institutional Investor Meetings with the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1914.70
Dr. Reddys Labs. 1386.00
Cipla 1413.40
Lupin 2018.15
Zydus Lifesciences 1227.50
View more..